TrimGen
Pre-clinicalTrimGen's STA technology is a unique fragment analysis method that accurately identify mutations.
Founded
2004
Focus
Genetics & Genomics
About
TrimGen's STA technology is a unique fragment analysis method that accurately identify mutations.
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedJun 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2004
LocationSparks, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile